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ing unit of the AustraliSummary There is increasing evidence that antibiotics have limited value for
many respiratory illnesses. This study investigates changes in overall antibiotic
prescribing rates, and rates for specific conditions, by Australian general practi-
tioners (GPs) between 1990–91 and 2002–03.
This is a comparative study of two cross-sectional surveys of general practice
activity, the Australian Morbidity and Treatment Survey (AMTS) 1990–91 and
Bettering Evaluation and Care of Health (BEACH) 2002–03. Both studies used random
samples of GPs, each providing data about a cluster of patient encounters. Outcome
measures are the antibiotic prescribing rate per 100 encounters or per 100 selected
problems managed.
Between 1990–91 and 2002–03, the overall antibiotic prescribing rate decreased
24.3% from 18.9 prescriptions per 100 encounters to 14.3 (Po0:001). For children,
the decrease for acute upper respiratory tract infection (URTI) was from 39.0 per 100
URTI problems to 24.4 (Po0:001), while the antibiotic prescribing rate increased for
acute otitis media, decreased for bronchitis/bronchiolitis, and remained unchanged
for other respiratory problems analysed. For adults the antibiotic prescribing rate for
URTI decreased from 58.2 per 100 URTI problems to 40.0 (Po0:001), increased
significantly for sinusitis and remained unchanged for all other respiratory
problems.
Antibiotic prescribing decreased significantly between 1990–91 and 2002–03 but
the decrease was selective.
The decline has been more pronounced among children than adults, and
particularly for URTI. While the message of educators may be achieving its goalElsevier Ltd. All rights reserved.
354 0618; fax: +61 2 9845 8155.
du.au (J. Henderson).
an Institute of Health and Welfare.
ARTICLE IN PRESS
Changes in antibiotic prescribing by Australian GPs 2005for URTI, other approaches targeting specific respiratory problems may be required
to reduce antibiotic prescribing in these areas.
& 2006 Elsevier Ltd. All rights reserved.Introduction
In recent years undue use of antibiotics has
emerged as a major contributing factor to anti-
microbial resistance internationally.1 Previous re-
search has shown that antibiotics have a limited
effect on many conditions such as upper respiratory
tract infection (URTI),2 sinusitis, acute otitis media
(AOM),3 tonsillitis, and acute bronchitis.4,5 Despite
the growing body of evidence, conditions which
typically do not benefit from antibiotics represent a
substantial proportion of total antibiotic prescrip-
tions to children in the United States (US) each
year.5
Antibiotic resistance has become a global con-
cern. Work by bodies such as the American Society
of Microbiology, the House of Lords Select Commit-
tee, the European Union, and the World Health
Organisation,1 has resulted in a strategy adopted by
many countries to combat this problem. The
themes on which this strategy is based include
improving microbiological surveillance, monitoring
drug utilisation, promoting prudent prescribing,
educating professionals and the general public,
promoting infection control and hygiene and
encouraging new drug and vaccine development.
While prescribing in all areas is being targeted, the
focus is on the community, where 80% of antibiotic
prescribing occurs.1
Australian concern reflects the international
stance.6 Over the past two decades general
practitioner (GP) educators and other bodies have
attempted to convince both practitioners and the
general public of the limited benefits of antibiotics
for many respiratory illnesses in an effort to reduce
unnecessary prescribing and thereby slow the rate
of anti-microbial resistance. Organisations such as
the Health Insurance Commission,7 the Australian
Department of Health and Ageing,8 State/Territory
health departments, the Australian Division of
General Practice9 and more recently, the National
Prescribing Service,10 have developed and provided
therapeutic guidelines, educational programs and
visits, individual prescribing feedback, clinical
audits and case studies for GPs, as well as printed
educational material for patients. These programs
have achieved some success in reducing antibiotic
prescribing overall, demonstrated in results from
the Bettering the Evaluation and Care of Health
(BEACH) program which has reported a realdecrease in antibiotic prescribing over the 5 years
to 2003.11
Studies in the US12 and the United Kingdom
(UK)13,14 have also reported a reduction in the rate
of anti-microbial prescribing in the past decade.
However, the decrease has not been uniform for
patients of different age groups, or for respiratory
problems overall. Some researchers concluded that
the reduction in antibiotic prescribing was, in part,
due to fewer consultations for common respiratory
infections,13 or a reduction in the incidence of
respiratory tract infections.14 Whether these trends
are also occurring in Australia has not been
examined.
In 1995 McManus et al. reported that between
1985 and 1994 antibiotic use in the Australian
community was the second highest in the world,
although it did not increase during the 1990s as it
did in most other countries.15 While some Austra-
lian researchers have suggested there is relatively
little benefit for antibiotic use in AOM in chil-
dren,16,17 for treatment of sore throat18 or for
URTIs,19 there is little research on true antibiotic
prescribing rates for selected problems in Australia.
This study compares two cross-sectional surveys of
Australian general practice activity to investigate
whether any changes have occurred in the anti-
biotic prescribing rate for selected problems over
the decade 1990–91 to 2002–03.Methods
Our study is a secondary comparative analysis of
data from the year-long, national Australian mor-
bidity and treatment survey 1990–91 (AMTS)20 and
the fifth year (2002–03) of the national BEACH
program.11Data sets
The methods of data collection in the two studies
have been published in detail elsewhere11,20 and
are only summarised here.
In the AMTS 1990–91, a random sample of 495
GPs (stratified by state) each recorded details of
surgery and home encounters for two periods of 1
week, 6 months apart, the weeks being spread as
evenly as possible across the year.20 Problems
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tional Classification of Primary Care.21 In 2002–03 a
random sample of 1008 GPs (20 GPs per week over 50
weeks from April 2002 to March 2003) each recorded
details of 100 consecutive patient encounters wher-
ever they occurred.11 Problems managed were
classified according to the International Classification
of Primary Care Version 2 (ICPC-2).22 In each study
the GP sample was compared with the population of
available practitioners (the sample frame) and
weighted where necessary to ensure that the sample
and encounters were representative of their respec-
tive populations in Australia at that time.
In both studies details of patient encounters
were recorded by GPs on standardised paper forms.
Data elements included patient age, sex, and status
to the practice (new/seen before); problems
managed (up to four) and medications prescribed
or supplied directly by the GP (up to four per
problem). Participating GPs also completed a
questionnaire about themselves and their practice.
Medications in both studies were classified accord-
ing to an in-house classification known as CAPS
(Coding Atlas for Pharmaceutical Substances). In
2002–03 medications advised for over-the-counter
purchase were recorded, as were encounters where
the patient was not seen and those that were
conducted in a hospital or aged care facility. These
were removed for this analysis to ensure compar-
ability with the 1990–91 AMTS, as these items were
not collected in the earlier study. Ten GPs from the
BEACH 2002–03 sample were excluded because
their 100 patient encounters were all recorded in a
hospital outpatients setting.
The study samples were 98,796 patient encoun-
ters from 495 GPs in 1990–91 and 90,833 patient
encounters from 998 GPs in 2002–03. Antibiotics in
this paper include antibacterial agents (excluding
anti-mycobacterial agents) commonly given
through oral or parenteral form.Statistical methods
Results are reported as rates per 100 encounters (or
per 100 problems) when an event can occur more
than once per encounter (or per problem) and as
proportions (%) when describing the distribution of
an event that can arise once per encounter (or
problem). If two antibiotics were prescribed at the
same encounter (or for the same problem), these
are counted as two prescriptions in this analysis.Descriptive and univariate analysis
Frequency tables for each study period were
used to identify the most common problems forwhich an antibiotic was prescribed. Simple
linear regression was used to identify GP and
patient characteristics that had a significant un-
adjusted relationship to overall antibiotic prescrib-
ing (a ¼ 0.05). Variables examined at the
univariate level included GP characteristics (GP
age; GP sex; Fellowship of the Royal Australian
College of General Practitioners (FRACGP); size of
practice; location of practice; place of graduation
(Australia vs. overseas) for primary medical degree)
and patient characteristics (patient age; patient
sex; new patient or seen previously at the
practice).Overall antibiotic prescribing
Multiple regression was used to examine the
change over time in overall prescribing after
adjusting for GP and patient characteristics
and morbidity managed. The model included all
GP and patient variables that were identified as
significant in the univariate analysis above
(a ¼ 0.05). Morbidity included all problems mana-
ged at the encounter, classified to the ICPC-2 body
chapters22 and identified as significant in the
univariate analysis.Antibiotic prescribing for the most common
problems
A series of regression models were used to examine
the changes over time in the rate of antibiotic
prescribing for each of the most common problems
receiving an antibiotic prescription, after adjusting
for GP and patient characteristics identified as
significant in the univariate analysis.
Both the AMTS and BEACH studies used random
samples of GPs, each providing data about a
cluster of encounters. To control for this design
effect, we adjusted for clustering at individual GP
level using SAS version 8.2 procedures.23 All
reported P values and 95% Confidence Intervals
(CIs) are based on the standard error, adjusted
using the robust variance estimator method accord-
ing to Kish’s formula.24Ethics approval
The AMTS was approved by the National Health and
Medical Research Council Ethics Committee. The
BEACH study is approved by the Ethics Committee
of the University of Sydney and the Health and
Welfare Ethics Committee of the Australian Insti-
tute of Health and Welfare.
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Encounters and problems managed
There were 145,799 problems managed at the
98,796 patient encounters in 1990–91, and
132,239 problems managed at the 90,833 encoun-
ters in 2002–03. In 1990–91 there were 15,655
encounters with children aged less than 15 years, at
which 19,038 problems were managed. In 2002–03
14,648 problems were managed at 12,653 encoun-
ters with patients in this age group. For patients
aged 15 years or more, there were 82,057
encounters in 1990–91 at which 124,993 problems
were managed, while in 2002–03 there were
116,561 problems managed at 77,477 encounters.Overall prescribing rates based on patient
encounters
The significant independent variables associated
with antibiotic prescribing were GP sex, FRACGP,
patient sex, patient age, new patient (to practice)
status, and morbidity under management at ICPC-2
chapter level (Table 1).Table 1 Variables with significant univariate association
GP and patient variables Number of
encounters
Sex of GPs
Male 151,140
Female 38,488
Fellow of RACGP
Yes 50,589
No 138,155
Sex of patients
Male 78,810
Females 108,296
Age of patients
o1 4049
1–4 10,170
5–14 14,089
15–24 19,983
25–44 48,862
45–64 45,912
65–74 23,482
X75 21,295
Patient status
New to practice 15,509
Seen before at practice 164,980
Fellow of RACGP ¼ Fellow of Royal Australian College of General
P-value is from F-test in univariate analysis, after adjusting fThere was no association between antibiotic
prescribing rates and GP age, years in general
practice, size, or location (rural vs. metropolitan)
of practice.
After adjusting for the confounding effect of the
significant GP and patient characteristics and
morbidity identified in the univariate analysis, the
antibiotic prescribing rate decreased between
1990–91 and 2002–03 by 24.3% from 18.9 (95% CI:
18.2–19.5) to 14.3 (95% CI: 13.7–14.8) prescriptions
per 100 encounters (Po0:001). Among children the
decrease was larger, down by 30.7% from 33.2 (95%
CI: 31.8–34.5) prescriptions per 100 encounters to
23.0 (95% CI: 21.6–24.4) per 100 (Po0:001). For
adults the rate decreased by 20.4% from 16.2 (95%
CI: 15.6–16.8) per 100–12.9 (95% CI: 12.4–13.4) per
100 encounters (Po0:001) (results not tabulated).
The indications accounting for the majority of
antibiotic prescriptions were identified from the
two data sets. The same six problems (five
respiratory problems and urinary tract infection
(UTI)) were the top six in both data sets. Together
these problems accounted for approximately two-
thirds of all problems managed with at least one
antibiotic in 1990–91 and 2002–03, respectively
(Table 2).with antibiotic prescribing rate.
Rate per 100
encounters
95% CI P-value
o0.001
17.1 16.6–17.6
15.1 14.2–16.0
o0.001
15.1 14.4–15.9
17.2 16.7–17.8
17.3 16.8–17.8 o0.001
16.2 15.7–16.6
o0.001
15.0 13.7–16.3
32.2 30.8–33.6
30.0 28.8–31.2
22.7 21.8–23.5
16.5 16.0–17.1
13.1 12.6–13.6
10.8 10.3–11.3
9.7 9.2–10.2
20.5 19.5–21.5 o0.0001
16.3 15.8–16.7
Practitioners.
or the design effect at the level of GP.
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Table 2 Most frequent problems for which an antibiotic was prescribed in 1990–91 and 2002–03.
Problem managed Number (%)
1990–91 2002–03
(n ¼ 18; 260) (n ¼ 12; 729)
Upper respiratory tract infection 3548 (19.4) 2088 (16.4)
Acute bronchitis/bronchiolitis 2745 (15.0) 1845 (14.5)
Tonsillitis 1560 (8.5) 953 (7.5)
Acute otitis media 1472 (8.1) 1015 (8.0)
Sinusitis 1283 (7.0) 1010 (7.9)
Urinary tract infection 1111 (6.1) 1061 (8.3)
Total of top six problems 11,719 (64.2) 7972 (62.6)
Includes multiple ICPC-2 rubrics.
Table 3 Antibiotic prescribing rates per 100 problems managed at encounters with children in 1990–91 and
2002–03.
Selected
problem
1990–91 2002–03 P-value
Number of
problems
Rate per 100
problems (95%
CI)
Number of
problems
Rate per 100
problems (95%
CI)
URTI 2779 39.0 (35.7–42.4) 2,267 24.4 (20.1–28.7) o0.001
Acute
bronchitis/
bronchiolitis
827 76.4 (72.6–80.2) 472 64.0 (56.6–71.4) 0.027
Sinusitis 185 81.8 (75.7–87.9) 93 81.7 (68.1–95.2) 0.64
Tonsillitisy 947 90.3 (88.1–92.5) 486 90.8 (87.3–94.2) 0.94
AOM 1472 77.6 (74.9–80.2) 884 84.4 (81.6–87.2) 0.002
UTIy 145 63.4 (55.3–71.5) 138 54.0 (44.3–63.7) 0.034
Note: URTI-upper respiratory tract infection; AOM-acute otitis media; UTI-urinary tract infection.
P-value is from t test in multiple regression, after controlling for the confounding influence of identified GP and patient
characteristics.
yIncludes multiple ICPC-2 rubrics.
Y. Pan et al.2008Problem based prescribing rate at
encounters with children
At encounters with children, the antibiotic pre-
scribing rate for URTI decreased significantly. There
were similar reductions in the prescribing rates for
acute bronchitis/bronchiolitis and UTI. However,
the antibiotic prescribing rate increased signifi-
cantly for AOM/myringitis. The prescribing rates
did not change for sinusitis and tonsillitis among
children (Table 3).Problem based prescribing rate at
encounters with adults
Antibiotic prescribing for URTI decreased signifi-
cantly for adults. In contrast, antibiotic prescribing
for sinusitis increased significantly. No significantchanges in antibiotic prescribing were observed for
acute bronchitis/bronchiolitis, tonsillitis, or for
AOM/myringtis in the adult group (Table 4).Discussion
This study has shown that there was a significant
decrease in the overall antibiotic prescribing rate
of GPs in Australia in the study decade. The
decrease was not consistent across age groups or
indications, being greater among children than
adults. Antibiotics were prescribed less often for
the management of URTI among both children and
adults during the study period.
In 2002, Zwar et al. suggested that antibiotic
prescribing was possibly associated with GP sex and
age, although a statistical relationship could not be
established, possibly due to insufficient statistical
ARTICLE IN PRESS
Table 4 Antibiotic prescribing rates per 100 problems managed at encounters with adults in 1990–91 and
2002–03.
Selected
problem
1990–91 2002–03 P-value
Number of
problems
Rate per 100
problems (95%
CI)
Number of
problems
Rate per 100
problems (95%
CI)
URTI 4175 58.6 (55.5–61.6) 3798 40.3 (36.5–44.0) o0.001
Acute
bronchitis/
bronchiolitis
2632 80.3 (78.2–82.4) 1852 83.3 (80.4–86.1) 0.17
Sinusitis 1452 77.6 (74.5–80.7) 1123 83.3 (80.5–86.2) 0.019
Tonsillitisy 757 97.6 (95.3–99.9) 547 95.7 (92.5–98.9) 0.15
AOM 442 74.6 (70.3–78.9) 337 79.6 (74.2–85.0) 0.30
UTIy 1467 68.5 (65.8–71.2) 1337 73.2 (70.3–76.1) 0.12
Note: URTI-upper respiratory tract infection; AOM-acute otitis media; UTI-urinary tract infection.
P-value is from t-test in multiple regression, after controlling for the confounding influence of identified GP and patient
characteristics.
yIncludes multiple ICPC-2 rubrics.
Changes in antibiotic prescribing by Australian GPs 2009power.25 Certified GPs (Fellows of the RACGP) have
been found to prescribe fewer antibiotics for URTI
than their non-certified counterparts,26 and Akker-
man et al. found that patient age can be a
predictor for antibiotic prescribing.27 Our study
supports these hypotheses, that antibiotic prescrib-
ing is related to GP sex, FRACGP status, and patient
age. However, after adjusting for these confound-
ing variables, changes in antibiotic prescribing
rates remained significant.
These results were consistent with the afore-
mentioned US12 and UK13,14 studies, both in the
reduction in anti-microbial prescribing, and in the
inconsistency of the reduction for patient age
groups and indications. However, we found no
evidence to suggest that the decrease was related
to a reduced management rate. Our study controls
for any change in the presentation rate for a
selected problem by measuring prescribing rates
for each condition. Charles et al. demonstrated
that there was a decrease in the management rate
of AOM and bronchitis in Australian children
between 1990–91 and 2000–01, in parallel with a
significant decrease in the overall prescribing rate
of antibiotics to children during that period.28 This
study has been able to demonstrate that this
decrease in overall antibiotic prescribing did not
apply to AOM—the rate of antibiotic prescribing
actually increased over time for this condition in
children.
The demonstrated decrease in prescribing of
antibiotics for URTI overall and for acute bronchi-
tis/bronchiolitis in children, may reflect a positive
response to the efforts of various bodies to educate
both clinicians and members of the public thatantibiotics are of little value in the treatment of a
viral URTI. The re-education process for GPs is
evident in the changes to antibiotic therapeutic
guidelines over the past two decades. In the 1984
edition, while acknowledging that ‘less than 50% of
sore throats are of bacterial origin and many will
not need treatment with antibiotics at all’ bacteria
were described as the common cause of sinusitis,
otitis media, and chronic bronchitis.29 In the 1990/
91 edition, these conditions were reported to be
mainly of viral origin and antibiotics were not
recommended for their management.30 The 2000
edition reinforces that the cause of URTI ‘is almost
invariably viral’ and restates that virus is also the
most likely cause of the other respiratory problems
mentioned above.31
The advisability of prescribing antibiotics for
respiratory illnesses other than URTI is contentious
because the effect of antiobiotics is controversial.
In 1994, a meta-analysis showed antibiotic therapy
had a modest but significant effect in AOM among
children.32 A more recent study by Takata et al.
supported this finding but proposed that antibiotic
use has limited effect on AOM without suppurative
complications, and that the majority of AOM
resolves spontaneously in children.33 From a review
of randomised controlled trials comparing anti-
microbial drugs with placebo in children with AOM,
Glasziou et al. reported no reduction in pain at
24 hours, but a 30% relative reduction (95%CI:
19.0–40.0) in pain at 2–7 days.17 We have de-
monstrated that amidst such results GPs have
increased, rather than decreased their pre-
scribing of antibiotics for AOM, one of the most
common problems managed by GPs for children in
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persuasive than ‘modest’ and ‘limited effect’ when
the decision to prescribe is made.
This study has examined the status of antibiotic
prescribing for selected respiratory problems by
Australian GPs over the decade 1990–91 to
2002–03. A limitation of the study is that we were
unable to determine how many of the prescriptions
written were actually filled at a pharmacy for
either the AMTS or BEACH. Its strengths lie in the
similarities of the two data sets—large sample sizes
repeatedly demonstrated to be representative of
Australian general practice, small clusters, similar
methods, similar classification systems for pro-
blems and medications, and two members of the
original AMTS research team involved with BEACH.
The similarities have enabled us to reliably deter-
mine that, despite the influences of GP or patient
characteristics, a real change in antibiotic pre-
scribing has occurred.
This study does not support the findings of the US
and the UK studies, that the reduction in antibiotic
prescribing is attributable to fewer consultations
for respiratory problems12,13 or a reduction in the
incidence of respiratory infections.14 Antibiotic
prescribing decreased significantly between
1990–91 and 2002–03 independent of changes in
characteristics of GPs, patients or morbidity, but
the decrease was selective. The decline has been
more pronounced among children than adults, and
particularly for URTI. The message of educators to
both clinicians and the public may well be achiev-
ing its goal for URTI, but seems to be missing the
mark for other indications. Other approaches
targeting specific respiratory problems may be
required to reduce antibiotic prescribing in these
areas.Acknowledgements
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